Join
Live feed
·
PRReleasevia Quantisnow
Beyond Air Inc. logo

Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)

ByQuantisnow·Wall Street's wire, on your screen.
XAIR· Beyond Air Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XAIR (Beyond Air Inc.) and more on Quantisnow.